Vincent T. DeVita Jr.
E304288
Vincent T. DeVita Jr. is a prominent American oncologist and former director of the National Cancer Institute, known for pioneering combination chemotherapy treatments for cancer.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Vincent T. DeVita Jr. canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T2825243 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: Vincent T. DeVita Jr. Context triple: [Yale School of Medicine, hasNotableFaculty, Vincent T. DeVita Jr.]
-
A.
Sidney Farber
Sidney Farber was an American pathologist and pioneering oncologist often called the "father of modern chemotherapy" for his groundbreaking work in treating childhood leukemia.
-
B.
Charles Janeway Jr.
Charles Janeway Jr. was a pioneering American immunologist whose work helped establish modern immunology, particularly through his insights into innate immunity and his influential textbook "Immunobiology."
-
C.
Dr. Robert B. Hayling
Dr. Robert B. Hayling was a prominent civil rights leader and dentist who played a key role in organizing and leading nonviolent protests against racial segregation in St. Augustine, Florida, during the early 1960s.
-
D.
Robert Iscove
Robert Iscove is a Canadian film and television director and choreographer best known for helming popular musical and teen-oriented projects such as the 1997 TV musical "Cinderella" and the film "She's All That."
-
E.
Eric E. Osmond
Eric E. Osmond is a film editor best known for his work on the animated feature "The Super Mario Bros. Movie."
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: Vincent T. DeVita Jr. Target entity description: Vincent T. DeVita Jr. is a prominent American oncologist and former director of the National Cancer Institute, known for pioneering combination chemotherapy treatments for cancer.
-
A.
Sidney Farber
Sidney Farber was an American pathologist and pioneering oncologist often called the "father of modern chemotherapy" for his groundbreaking work in treating childhood leukemia.
-
B.
Charles Janeway Jr.
Charles Janeway Jr. was a pioneering American immunologist whose work helped establish modern immunology, particularly through his insights into innate immunity and his influential textbook "Immunobiology."
-
C.
Dr. Robert B. Hayling
Dr. Robert B. Hayling was a prominent civil rights leader and dentist who played a key role in organizing and leading nonviolent protests against racial segregation in St. Augustine, Florida, during the early 1960s.
-
D.
Robert Iscove
Robert Iscove is a Canadian film and television director and choreographer best known for helming popular musical and teen-oriented projects such as the 1997 TV musical "Cinderella" and the film "She's All That."
-
E.
Eric E. Osmond
Eric E. Osmond is a film editor best known for his work on the animated feature "The Super Mario Bros. Movie."
- F. None of above. chosen
Statements (46)
| Predicate | Object |
|---|---|
| instanceOf |
American
ⓘ
cancer researcher ⓘ medical researcher ⓘ oncologist ⓘ person ⓘ physician ⓘ |
| authorOf |
Cancer: Principles & Practice of Oncology
ⓘ
The Death of Cancer ⓘ |
| awardReceived |
Albert Lasker Clinical Medical Research Award
ⓘ
American Cancer Society Medal of Honor ⓘ Karnofsky Memorial Award ⓘ |
| citizenship | United States of America ⓘ |
| coAuthor | The Death of Cancer ⓘ |
| educatedAt |
College of William & Mary
ⓘ
George Washington University ⓘ
surface form:
George Washington University School of Medicine
|
| employer |
National Cancer Institute
ⓘ
National Institutes of Health ⓘ Yale Cancer Center ⓘ Yale School of Medicine ⓘ |
| fieldOfWork |
cancer chemotherapy
ⓘ
medical oncology ⓘ oncology ⓘ |
| genre |
medical textbook
ⓘ
popular science ⓘ |
| hasAcademicDegree | MD ⓘ |
| influenced |
curative treatment strategies for Hodgkin lymphoma
ⓘ
modern combination chemotherapy protocols ⓘ |
| knownFor |
development of MOPP regimen for Hodgkin lymphoma
ⓘ
development of combination chemotherapy for Hodgkin lymphoma ⓘ pioneering combination chemotherapy for cancer ⓘ |
| languageSpoken | English ⓘ |
| memberOf |
American Association for Cancer Research
ⓘ
American Society of Clinical Oncology ⓘ National Academy of Medicine ⓘ
surface form:
Institute of Medicine of the National Academy of Sciences
|
| nationality | American ⓘ |
| notableWork | Cancer: Principles & Practice of Oncology ⓘ |
| occupation |
author
ⓘ
doctor ⓘ medical administrator ⓘ university professor ⓘ |
| positionHeld |
director of Yale Cancer Center
ⓘ
director of the National Cancer Institute ⓘ physician-in-chief at Yale–New Haven Hospital ⓘ |
| specialty |
Hodgkin lymphoma
ⓘ
lymphoma ⓘ solid tumors ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: Vincent T. DeVita Jr. Description of subject: Vincent T. DeVita Jr. is a prominent American oncologist and former director of the National Cancer Institute, known for pioneering combination chemotherapy treatments for cancer.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.